electroCore (ECOR) Non-Current Debt (2020 - 2026)

electroCore (ECOR) posted quarterly Non-Current Debt of $6.4 million for Q1 2026, down 2.57% quarter-over-quarter from $6.6 million in Q4 2025.

electroCore (ECOR) Non-Current Debt (2020 - 2026) Analysis & Trends

electroCore's Non-Current Debt history runs 4 years deep, the most recent figure standing at $6.4 million for Q1 2026.

In Q1 2026, Non-Current Debt changed N/A year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (changed N/A YoY), while the FY2025 annual figure was $6.6 million, changed N/A from the prior year.
Non-Current Debt for Q1 2026 stood at $6.4 million, down from $6.6 million in the prior quarter.
The five-year high for Non-Current Debt was $6.6 million in Q4 2025, with the low at $6.4 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	29.60 Bn
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	14.19 Bn
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	10.92 Bn
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	10.09 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	7.34 Bn
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	1.65 Bn
10	electroCore	92.63 Mn	82.59 Mn	8.18 Mn	5.77 Mn

Download Data